Vancouver, British Columbia–(Newsfile Corp. – June 20, 2024) – Trenchant Technologies Capital Corp. (CSE: AITT) (OTC: AITTF) ("Trenchant" or the "Company") announces that, further to its News Release of June 12, 2024, it has completed…

GNQ Insilico's ("GNQ") proprietary genomics-driven platform is leveraging Artificial Intelligence (AI) and Quantum Computing technologies to create "intelligent digital twins" of human patients that can mimic how a drug will interact with an individual patient's…

Vancouver, British Columbia–(Newsfile Corp. – May 1, 2024) – Trenchant Capital Corp. (CSE: TCC) (the "Company") is pleased to announce that pursuant to an option agreement between the Company and GNQ Insilico Inc. ("GNQ") dated…

Vancouver, British Columbia–(Newsfile Corp. – March 6, 2024) – Trenchant Capital Corp. (CSE: TCC) (the "Company") announces that GNQ Insilico Inc. ("GNQ") has reported that it has commenced the development of an in silico clinical…

Vancouver, British Columbia–(Newsfile Corp. – January 4, 2024) – Trenchant Capital Corp. (CSE: TCC) (the "Company") is pleased to announce that it has entered into an amendment agreement (the "Amendment Agreement") to the previously announced…